Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus.
暂无分享,去创建一个
Joseph W Hogan | Daniel O Scharfstein | Michael J Daniels | Tianjing Li | Kay Dickersin | Roderick J A Little | Jason A Roy | R. Little | M. Daniels | D. Scharfstein | K. Dickersin | Tianjing Li | J. Roy | J. Hogan | Susan Hutfless | Andrew H Law | S. Hutfless | Andrew Law | Susan Hutfless
[1] A. Barton. Handbook for good clinical research practice (GCP): guidance for implementation , 2007, Journal of Epidemiology and Community Health.
[2] R. Guy,et al. International Conference on Harmonisation , 2014 .
[3] Michael L. Johnson,et al. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[4] C D Naylor,et al. Dealing with missing data in observational health care outcome analyses. , 2000, Journal of clinical epidemiology.
[5] Paula Diehr,et al. Imputation of missing longitudinal data: a comparison of methods. , 2003, Journal of clinical epidemiology.
[6] S. Greenfield,et al. COMMITTEE ON STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES , 2011 .
[7] Mirjam Kretzschmar,et al. Dynamic Transmission Modeling , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] R. Kay. Statistical Principles for Clinical Trials , 1998, The Journal of international medical research.
[9] Meera Viswanathan,et al. Comparative Effectiveness Review Methods: Clinical Heterogeneity , 2010 .
[10] A. Carr,et al. Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. , 1998, Health technology assessment.
[11] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[12] Uwe Siebert,et al. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retr , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] N. Dreyer,et al. Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .
[14] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[15] Zhang Jing,et al. Guideline on missing data in confirmatory clinical trials , 2012 .
[16] McGinnis Jm,et al. The learning healthcare system : workshop summary , 2007 .
[17] A. Dobson,et al. RE: “QUALITY OF REPORTING OF OBSERVATIONAL LONGITUDINAL RESEARCH” , 2005 .
[18] Haitao Chu,et al. On estimation of vaccine efficacy using validation samples with selection bias. , 2006, Biostatistics.
[19] R. Willke,et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] Jonathan Karnon,et al. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[21] LeighAnne Olsen,et al. IOM Roundtable on Evidence-Based Medicine , 2007 .
[22] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Obstetrics and gynecology.
[23] Global Sensitivity Analysis for Randomized Trials with Informative Dropout: A Semiparametric Perspective , 2009 .
[24] Laura A. Levit,et al. Finding what works in health care : standards for systematic reviews , 2011 .
[25] R. Little,et al. The design and conduct of clinical trials to limit missing data , 2012, Statistics in medicine.
[26] D. Rubin. Multiple imputation for nonresponse in surveys , 1989 .
[27] L. Garrison,et al. Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[28] T. Stijnen,et al. Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.
[29] Joseph C Cappelleri,et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[30] A. Rotnitzky,et al. Missing Data in Longitudinal Studies: Strategies for Bayesian Modeling and Sensitivity Analysis by DANIELS, M. J. and HOGAN, J. W , 2009 .
[31] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.
[32] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[33] D Scharfstein,et al. Methods for Conducting Sensitivity Analysis of Trials with Potentially Nonignorable Competing Causes of Censoring , 2001, Biometrics.
[34] Sharon-Lise Normand,et al. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[35] S Greenland,et al. A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.
[36] Qingxia Chen,et al. Missing covariate data in medical research: to impute is better than to ignore. , 2010, Journal of clinical epidemiology.
[37] T. Fleming. Addressing Missing Data in Clinical Trials , 2011, Annals of Internal Medicine.
[38] John P. A. Ioannidis,et al. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. , 2012, JAMA.
[39] Ian R White,et al. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals , 2004, Clinical trials.
[40] D. Rubin,et al. Statistical Analysis with Missing Data. , 1989 .
[41] Joseph W Hogan,et al. Handling drop‐out in longitudinal studies , 2004, Statistics in medicine.
[42] Sharon-Lise T Normand,et al. Getting the methods right--the foundation of patient-centered outcomes research. , 2012, The New England journal of medicine.
[43] D. Spiegelhalter,et al. Consensus development methods, and their use in clinical guideline development. , 1998, Health technology assessment.
[44] Peter Davey,et al. A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.